29 January 2024 in Clinical nutrition and metabolism
КВКнязева Анастасия Вячеславовна
Князева Анастасия Вячеславовна
+3
BACKGROUND: Patients with breast cancer in remission tend to be overweight; however, the global literature has no data on eating disorders in this category of women. AIM: To identify any potential eating disorders and their association with personality traits and emotional condition of women who underwent radical treatment for breast cancer and do not show any disease progression. MATERIALS AND METHODS: Thirty-two women who completed breast cancer treatment and did not show any disease progression in one year were asked to fill in Eating Attitude Test (EAT-26) and Big Five personality test and were evaluated with the Hospital Anxiety and Depression Scale (HADS). Microsoft Excel and Statistica 10.0 were used for statistical data processing. The critical significance level was p 0.05. RESULTS: 81.3% of the patients were overweight. A serious eating disorder was found in one patient. In 15.6% of patients were was evidence of strained relationship food. A statistically significant association was established between Neuroticism and Depression ( r =0.362) and between Agreeableness and Level of anxiety ( r =0.37). No correlation was discovered for the probability of an eating disorder and “level of anxiety/depression.” CONCLUSION: Serious eating disorders seem to be uncharacteristic of patients with breast cancer who have completed the treatment. The following pairs of descriptors were found to be associated: Agreeableness/Anxiety and Neuroticism/Depression.
1 November 2023 in Clinical nutrition and metabolism
BACKGROUND: Although the critical role of vitamin D in mineral homeostasis regulation is widely recognized, the global prevalence of vitamin D deficiency is exceedingly high. The substantial number of population-based studies that examine the correlation between the concentration of circulating vitamin D levels and the risk of developing cancer may be attributed to the growing interest of researchers in this vitamin as a suppressor of proliferating epithelial cells. However, the data collected are contradictory. AIM: To ascertain the necessity of diagnosing and rectifying vitamin D deficiency in cancer patients. MATERIALS AND METHODS: The keywords “vitamin D,” “vitamin D deficiency,” “cancer,” and “survival” were employed to identify publications in the e-Library, PubMed, and ScienceDirect databases from January 2014 to January 2024. Based on the data obtained, an analytical review of the literature was conducted. RESULTS: The global prevalence of vitamin D deficiency, including among cancer patients, is exceedingly high and does not vary by sex, age, or ethnicity. Decreased serum vitamin D levels are linked to an elevated incidence of colorectal cancer, breast cancer, melanoma, prostate, and pancreatic cancer. Addressing vitamin D deficiency helped mitigate the risk of developing breast cancer. Data on the effect of vitamin D deficiency and its correction on patient survival are inconsistent. CONCLUSION: Currently, there is no consensus regarding the impact of vitamin D supplementation on the incidence of diverse malignancies, as well as tumor-specific and overall survival. Additional research is required to address the necessity of diagnosing and correcting vitamin D deficiency.